11,905 Shares in Privia Health Group, Inc. (NASDAQ:PRVA) Acquired by MQS Management LLC

MQS Management LLC bought a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 11,905 shares of the company’s stock, valued at approximately $217,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Canada Pension Plan Investment Board bought a new stake in shares of Privia Health Group during the second quarter valued at approximately $26,000. GAMMA Investing LLC raised its position in shares of Privia Health Group by 98.7% during the third quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock valued at $31,000 after buying an additional 845 shares during the last quarter. Nisa Investment Advisors LLC raised its position in shares of Privia Health Group by 107.5% during the second quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company’s stock valued at $31,000 after buying an additional 930 shares during the last quarter. Signaturefd LLC raised its position in shares of Privia Health Group by 46.3% during the second quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock valued at $34,000 after buying an additional 626 shares during the last quarter. Finally, Values First Advisors Inc. bought a new stake in Privia Health Group in the third quarter worth $83,000. Institutional investors own 94.48% of the company’s stock.

Insider Activity

In other news, CEO Parth Mehrotra sold 135,142 shares of the company’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the transaction, the chief executive officer now owns 247,771 shares in the company, valued at $4,583,763.50. This represents a 35.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Corporate insiders own 14.20% of the company’s stock.

Privia Health Group Stock Performance

Shares of Privia Health Group stock opened at $21.20 on Friday. The company has a market capitalization of $2.54 billion, a PE ratio of 212.00, a P/E/G ratio of 5.07 and a beta of 0.76. The company has a 50-day simple moving average of $18.71 and a two-hundred day simple moving average of $18.49. Privia Health Group, Inc. has a one year low of $15.92 and a one year high of $24.30.

Analysts Set New Price Targets

PRVA has been the topic of several research reports. Robert W. Baird boosted their price target on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a research report on Monday, August 26th. Royal Bank of Canada restated an “outperform” rating and issued a $28.00 price target on shares of Privia Health Group in a research report on Wednesday, August 14th. Truist Financial boosted their price target on shares of Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Barclays boosted their price target on shares of Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Friday, November 8th. Finally, KeyCorp started coverage on shares of Privia Health Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $23.00 price target on the stock. Two research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Buy” and a consensus price target of $25.07.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.